Table of Content

1 Industry Overview

• 1.1 Celecoxib Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Celecoxib
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Celecoxib Market by Type

• 3.1 By Type
  • 3.1.1 50mg Celecoxib
  • 3.1.2 100mg Celecoxib
  • 3.1.3 200mg Celecoxib
  • 3.1.4 400mg Celecoxib
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

• 4.1 Pfizer (Company Profile, Sales Data etc.)
• 4.2 Shire (Company Profile, Sales Data etc.)
• 4.3 Teva (Company Profile, Sales Data etc.)
• 4.4 Mylan (Company Profile, Sales Data etc.)
• 4.5 Chengdu Suncadia Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.6 Jiangsu Chiatai Qingjiang Pharmaceutical (Company Profile, Sales Data etc.)
• 4.7 Anhui Heyi Chemical (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Market Demand

• 6.1 Demand Situation
  • 6.1.1 Demand in Rheumatoid Arthritis
  • 6.1.2 Demand in Osteoarthritis
  • 6.1.3 Demand in Acute Pain
  • 6.1.4 Demand in Musculoskeletal Pain
  • 6.1.5 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Celecoxib

Table Application Segment of Celecoxib

Table Global Celecoxib Market 2013-2024, by Application, in USD Million

Table Major Company List of 50mg Celecoxib

Table Major Company List of 100mg Celecoxib

Table Major Company List of 200mg Celecoxib

Table Major Company List of 400mg Celecoxib

Table Global Celecoxib Market 2013-2018, by Type, in USD Million

Table Global Celecoxib Market Forecast 2019-2024, by Type, in USD Million

Table Pfizer Overview List

Table Celecoxib Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)

Table Shire Overview List

Table Celecoxib Business Operation of Shire (Sales Revenue, Cost, Gross Margin)

Table Teva Overview List

Table Celecoxib Business Operation of Teva (Sales Revenue, Cost, Gross Margin)

Table Mylan Overview List

Table Celecoxib Business Operation of Mylan (Sales Revenue, Cost, Gross Margin)

Table Chengdu Suncadia Pharmaceuticals Overview List

Table Celecoxib Business Operation of Chengdu Suncadia Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

Table Jiangsu Chiatai Qingjiang Pharmaceutical Overview List

Table Celecoxib Business Operation of Jiangsu Chiatai Qingjiang Pharmaceutical (Sales Revenue, Cost, Gross Margin)

Table Anhui Heyi Chemical Overview List

Table Celecoxib Business Operation of Anhui Heyi Chemical (Sales Revenue, Cost, Gross Margin)

Table Global Celecoxib Sales Revenue 2013-2018, by Company, in USD Million

Table Global Celecoxib Sales Revenue Share, by Company, in USD Million

Table Celecoxib Demand in Rheumatoid Arthritis, 2013-2018, in USD Million

Table Major Consumers in Rheumatoid Arthritis

Table Celecoxib Demand in Osteoarthritis, 2013-2018, in USD Million

Table Major Consumers in Osteoarthritis

Table Celecoxib Demand in Acute Pain, 2013-2018, in USD Million

Table Major Consumers in Acute Pain

Table Celecoxib Demand in Musculoskeletal Pain, 2013-2018, in USD Million

Table Major Consumers in Musculoskeletal Pain

Table Celecoxib Demand in Others, 2013-2018, in USD Million

Table Major Consumers in Others

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Celecoxib Demand Forecast 2019-2024, by Application, in USD Million

Table Celecoxib Production 2013-2018, by Region, in USD Million

Table Global Celecoxib Market 2013-2018, by Region, in USD Million

Table Global Celecoxib Market Share 2013-2018, by Region, in USD Million

Table North America Celecoxib Market Size 2013-2018, by Country, in USD Million

Table Europe Celecoxib Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Celecoxib Market Size 2013-2018, by Country, in USD Million

Table South America Celecoxib Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Celecoxib Market Size 2013-2018, by Country, in USD Million

Table Celecoxib Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

List of Figures

Figure Celecoxib Industry Chain Structure

Figure Global Celecoxib Market Growth 2013-2018, by Type, in USD Million

Figure North America Celecoxib Market, by Company, in 2018

Figure Europe Celecoxib Market Market, by Company, in 2018

Figure Asia-Pacific Celecoxib Market Market, by Company, in 2018

Figure South America Celecoxib Market Market, by Company, in 2018

Figure Middle East & Africa Celecoxib Market Market, by Company, in 2018

Figure North America Celecoxib Market Size and Growth 2013-2018, in USD Million

Figure Europe Celecoxib Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Celecoxib Market Size and Growth 2013-2018, in USD Million

Figure South America Celecoxib Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Celecoxib Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview

Snapshot
The global Celecoxib market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Celecoxib by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
50mg Celecoxib
100mg Celecoxib
200mg Celecoxib
400mg Celecoxib
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Pfizer
Shire
Teva
Mylan
Chengdu Suncadia Pharmaceuticals
Jiangsu Chiatai Qingjiang Pharmaceutical
Anhui Heyi Chemical
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Rheumatoid Arthritis
Osteoarthritis
Acute Pain
Musculoskeletal Pain
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)